Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-19-026446

Chief Executive Officer sold 7,800 shares at an average $33.54 ($261,582)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Ciechanover Isaac E. Chief Executive Officer 2019-04-25 Sale −3,600 $33.57 $120,852 308,537 I
Ciechanover Isaac E. Chief Executive Officer 2019-04-25 Sale −300 $33.99 $10,197 308,237 I
Ciechanover Isaac E. Chief Executive Officer 2019-04-26 Sale −3,900 $33.47 $130,533 304,337 I
Open-market sales · 7,800 sh · avg $33.54 · $261,582
Loading xslF345X03/doc4.xml…